India’s leading vaccine innovator Bharat Biotech has announced the establishment of a Contract Research, Development, and Manufacturing Organization (CRDMO) division dedicated to cell and gene therapy, marking a strategic expansion into one of the most advanced frontiers in biomedical science. The new CRDMO arm will focus
The Yamuna Expressway Industrial Development Authority (YEIDA) is all set to sign a Memorandum of Understanding (MoU) with a leading Japanese government agency — the Japan External Trade Organization (JETRO) — to collaborate on the development of a state-of-the-art Medical Device Park along the Yamuna
In a move to strengthen drug regulation and ensure the availability of safe, high-quality medicines, Uttar Pradesh Chief Minister Yogi Adityanath announced that the state government will double the number of drug inspectors across the state. The decision is aimed at improving the monitoring of
Built on the values of Confidence, Care and Science, KeyCi is rooted in dermatological research and sustainability Iberia Pharmaceuticals, a leading name in skincare, has launched KeyCi, a science-backed skincare brand designed for modern consumers aged 18–45. KeyCi offers high-performance, dermatologically tested products that are vegan,
Bioconjugation capability will complement commercial payload, linker and monoclonal antibodies services Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru. With this new capability, Syngene will offer fully
Investment in Belgium’s Frid Mind Technologies to Advance Stroke Prevention Acquisition of Stake in Israel’s Motion Informatics to Strengthen Stroke Rehabilitation Portfolio Development of advanced Braided Devices for Neurovascular and Peripheral Vascular Care Biorad Medisys Pvt. Ltd. today outlined a series of product development
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring novel therapies to market faster. The investments included a dedicated, state-of-the-art
Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda Eli Lilly and Company today announced plans to invest more than $1 Billion over the next several years into new contract manufacturing in India, expanding patients’ access to innovative
India’s healthcare stakeholders — including hospitals, diagnostic chains, medical device firms, insurers and pharma groups — have responded positively to the rollout of GST 2.0, saying the tax changes announced under Prime Minister Narendra Modi’s leadership will alleviate cost pressures, expand access, and give a
Poly Medicure Limited (Polymed), one of India’s leading medical device companies, today announced the acquisition of Citieffe Group, an Italy-based company specializing in orthopedic trauma and extremities devices, for an enterprise value of approximately ₹324 crore (€31 million). The acquisition has been executed through Medistream SA,
